Abstract
Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder characterized by variable age of onset, with no treatment proven to alter its natural history. Siblings of individuals with FRDA have a 25 % risk of developing the condition, raising issues around genetic testing of asymptomatic minors. There is a lack of professional consensus and limited empirical evidence to support provision or refusal of testing. This study aimed to ascertain the opinions of individuals with and parents of individuals with FRDA regarding pre-symptomatic testing of minors. A qualitative research approach using semi-structured interviews and thematic analysis was employed. Interviews with ten individuals with FRDA, and ten parents of individuals with FRDA were conducted, recorded, transcribed and analyzed. Four findings emerged. First, a number of arguments for and against testing minors were identified. Second, strong support existed from parents about the parental right to test their at-risk immature children, but individuals with FRDA were of mixed opinions. Third, participants felt it was not the clinician’s role to make a final decision about whether testing occurs. Finally, a specific issue of concern regarding testing was what and when to tell at-risk children about the test result. The findings highlight a dilemma of how to manage the desires of some individuals and families affected by FRDA to access testing, when there is a lack of professional consensus due to differing opinions regarding autonomy, confidentiality and risk of harm. Research regarding the impact of testing and the views of at-risk individuals and clinicians is required so an appropriate framework for dealing with this contentious issue is developed.
Similar content being viewed by others
References
American Academy of Pediatrics. (2013). Ethical and policy issues in genetic testing and screening of children. Pediatrics, 131, 620–622.
American Society of Human Genetics. (1995). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 57, 1233–1241.
Bloch, M., & Hayden, M. R. (1990). Opinion: predictive testing for huntington disease in childhood: challenges and implications. American Journal of Human Genetics, 46, 1–4.
Borry, P., Goffin, T., Nys, H., & Dierickx, K. (2008). Predictive genetic testing in minors for adult-onset genetic diseases. Mount Sinai Journal of Medicine, 75, 287–296.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77–101.
Canadian Paediatric Society. (2003). Guidelines for genetic testing of health children. Journal of Paediatrics and Child Health, 8, 42–45.
Clarke, A. (2010). What is at stake in the predictive genetic testing of children? Familial Cancer, 9, 19–22.
Clayton, E. W. (1997). Genetic testing in children. Journal of Medicine and Philosophy, 22, 233–251.
Corben, L. A., Georgiou-Karistianis, N., Bradshaw, J. L., Evans-Galea, M., Churchyard, A. J., & Delatycki, M. B. (2012). Characterising the neuropathy and neurobehavioural phenotype in Friedreich ataxia. Advances in Experimental Medicine and Biology, 769, 169–184.
Corben, L.A., Lynch, D., Pandolfo, M., Schulz, J.B.& Delatycki, M.B. (2014). Consensus Clinical Management Guidelines for Friedreich Ataxia. Orphanet Journal of Rare Diseases (in press- accepted 7 November 2014).
Daly, K. J. (2007). Qualitative methods for family studies & human development. Los Angeles: Sage Publications.
Delatycki, M. B., & Corben, L. A. (2012). Clinical features of friedreich ataxia. Journal of Child Neurology, 27, 1133–1137.
Duncan, R. E. (2004). Predictive genetic testing in young people: when is it appropriate? Journal of Paediatrics and Child Health, 40, 593–595.
Duncan, R. E., & Delatycki, M. B. (2006). Predictive genetic testing in young people for adult-onset conditions: where is the empirical evidence? Clinical Genetics, 69, 8–20.
Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2007). "Holding your breath": interviews with young people who have undergone predictive genetic testing for Huntington disease. American Journal of Medical Genetics Part A, 143A, 1984–1989.
Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2008). "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics Part C, 148C, 47–55.
Elger, B. S., & Harding, T. W. (2000). Testing adolescents for a hereditary breast cancer gene (BRCA1): respecting their autonomy is in their best interest. Archives of Pediatrics and Adolescent Medicine, 154, 113–119.
European Society of Human Genetics. (2009). Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. European Journal of Human Genetics, 17, 720–721.
Fenwick, A. (2010). Are guidelines for genetic testing of children necessary? Familial Cancer, 9, 23–25.
Fryer, A. (2000). Inappropriate genetic testing of children. Archives of Disease in Childhood, 83, 283–285.
Gilbar, R. (2010). Genetic testing of children for familial cancers: a comparative legal perspective on consent, communication of information and confidentiality. Familial Cancer, 9, 75–87.
Hanson, J. W., & Thomson, E. J. (2000). Genetic testing in children: ethical and social points to consider. Pediatric Annals, 29, 285–292.
Holland, J. (1997). Should parents be permitted to authorize genetic testing for their children? Family Law Quarterly, 31, 321–353.
Human Genetics Society of Australasia. (2008). Pre-symptomatic testing in children and young adults. Human Genetics Society of Australasia. Retrieved from: http://www.hgsa.org.au/resources/hgsa-policies-and-position-statements.
Japan Society of Human Genetics. (2001). Guidelines for genetic testing. Journal of Human Genetics, 46, 163–165.
Liamputtong, P. (2013). Qualitative research methods 4th edition. South Melbourne: Oxford University Press.
Lucassen, A., & Montgomery, J. (2010). Predictive genetic testing in children: where are we now? An overview and a UK perspective. Familial Cancer, 9, 3–7.
Malpas, P. (2005). Predictive genetic testing in children and respect for autonomy. The International Journal of Children's Rights, 13, 273–285.
Malpas, P. J. (2008). Predictive genetic testing of children for adult-onset diseases and psychological harm. Journal of Medical Ethics, 34, 275–278.
Mand, C., Gillam, L., Delatycki, M. B., & Duncan, R. E. (2012). Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments. Journal of Medical Ethics, 38, 519–524.
Mand, C., Gillam, L., Duncan, R. E., & Delatycki, M. B. (2013). "It was the missing piece": adolescent experiences of predictive genetic testing for adult-onset conditions. Genetics in Medicine, 15, 643–649.
Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing for Huntington's disease: an update of the literature. Journal of Neurology, Neurosurgery & Psychiatry, 69, 574–578.
Michie, S. (1996). Predictive genetic testing in children: paternalism or empiricism? In T. Marteau & M. Richards (Eds.), The troubled helix: Social and psychological implications of the new human genetics (pp. 177–186). Cambridge: Cambridge University Press.
National Society of Genetic Counselors. (2012). Genetic testing of minors for adult-onset conditions. National society of genetic counselors. Retrieved from: https://doi.org/nsgc.org/p/bl/et/blogid=47&blogaid=28.
Nelson, R. M., Botkin, J. R., Kodish, E. D., Levetown, M., Truman, J. T., Wilfond, B. S., et al. (2001). Ethical issues with genetic testing in pediatrics. Pediatrics, 107, 1451–1455.
Otlowski, M. (2004). An exploration of the legal and socio-ethical implications of predictive genetic testing of children. Australian Journal of Family Law, 18, 147–169.
Pandolfo, M. (2009). Friedreich ataxia: the clinical picture. Journal of Neurology, 256, 3–8.
Parker, M. (2010). Genetic testing in children and young people. Familial Cancer, 9, 15–18.
Parkinson, M. H., Boesch, S., Nachbauer, W., Mariotti, C., & Giunti, P. (2013). Clinical features of Friedreich's ataxia: classical and atypical phenotypes. Journal of Neurochemistry, 126, 103–117.
Patenaude, A. F. (1996). The genetic testing of children for cancer susceptibility: ethical, legal, and social issues. Behavioral Sciences and the Law, 14, 393–410.
Pelias, M. K. (2006). Genetic testing of children for adult-onset diseases: is testing in the child's best interests? Mount Sinai Journal of Medicine, 73, 605–608.
Quercia, N., Somers, G. R., Halliday, W., Kantor, P. F., Banwell, B., & Yoon, G. (2010). Friedreich ataxia presenting as sudden cardiac death in childhood: clinical, genetic and pathological correlation, with implications for genetic testing and counselling. Neuromuscular Disorders, 20, 340–342.
Rhodes, R. (2006). Why test children for adult-onset genetic diseases? Mount Sinai Journal of Medicine, 73, 609–616.
Richards, F. (2006). Maturity of judgement in decision making for predictive testing for nontreatable adult-onset neurogenetic conditions: a case against predictive testing of minors. Clinical Genetics, 70, 396–401.
Robertson, S., & Savulescu, J. (2001). Is there a case in favour of predictive genetic testing in young children? Bioethics, 15, 22–49.
Ross, L. F. (2004). Should children and adolescents undergo genetic testing? Pediatric Annals, 33, 762–769.
Rowland, E., & Metcalfe, A. (2013). Communicating inherited genetic risk between parent and child: a meta-thematic synthesis. International Journal of Nursing Studies, 50, 870–880.
Savulescu, J. (2001). Predictive genetic testing in children. Medical Journal of Australia, 175, 379–381.
Schulz, J. B., Boesch, S., Burk, K., Durr, A., Giunti, P., Mariotti, C., et al. (2009). Diagnosis and treatment of Friedreich ataxia: a European perspective. Nature Reviews Neurology, 5, 222–234.
Seeber, B., & Driscoll, D. A. (2004). Hereditary breast and ovarian cancer syndrome: should we test adolescents? Journal of Pediatric and Adolesccent Gynecology, 17, 161–167.
Sharpe, N. F. (1993). Presymptomatic testing for Huntington disease: is there a duty to test those under the age of eighteen years? American Journal of Medical Genetics, 46, 250–253.
Twomey, J. G. (2002). Genetic testing of children: confluence or collision between parents and professionals? AACN Clinical Issues, 13, 557–566.
Twomey, J. G. (2006). Issues in genetic testing of children. The American Journal of Maternal/Child Nursing, 31, 156–163.
Wertz, D. C., Fanos, J. H., & Reilly, P. R. (1994). Genetic testing for children and adolescents: who decides? Journal of the American Medical Association, 272, 875–881.
Wood, N. W. (1998). Diagnosing Friedreich's ataxia. Archive of Disease in Childhood, 78, 204–207.
Acknowledgments
The authors thank all participants who generously took the time to participate. RED was partly supported through The Invergowrie Foundation. LAC is an Early Career Fellow of the National Health and Medical Research Council (Australia). This study was supported by the Victorian Government's Operational Infrastructure Support Program.
Conflict of Interest
Authors Georgia C. Lowe, Louise A. Corben, Rony E. Duncan and Grace Yoon declare that they have no conflict of interest.
Author Martin B. Delatycki has received consultancy fees from AAVlife.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all participants for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lowe, G.C., Corben, L.A., Duncan, R.E. et al. “Both Sides of the Wheelchair”: The Views of Individuals with, and Parents of Individuals with Friedreich Ataxia Regarding Pre-symptomatic Testing of Minors. J Genet Counsel 24, 732–743 (2015). https://doi.org/10.1007/s10897-014-9801-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-014-9801-9